Core Viewpoint - Xiamen Adebiotech Co., Ltd. announced the repurchase and cancellation of restricted stocks involving 379 individuals, totaling 1,525,825 shares, which represents a reduction in the company's total share capital [1][5]. Summary by Sections Repurchase Details - The repurchase price for the restricted stocks is set at 11.62 CNY per share for the newly appointed supervisor, while for others, it includes the bank's current deposit interest [1][5]. - The total amount for this repurchase is 18,109,508.16 CNY [1][5]. Approval Process - The company has completed the necessary approval procedures for the incentive plan, including independent opinions from the board and verification from the supervisory board regarding the list of incentive objects [2][3]. Reasons for Repurchase - The repurchase is due to the departure of 9 individuals from the incentive plan and 1 individual being appointed as a supervisor, making them ineligible for the incentive [4][5]. - Additionally, the company needs to repurchase stocks corresponding to the second unlock period of the incentive plan due to unmet performance targets [5]. Impact on Share Structure - After the repurchase, the total share capital will decrease from 393,061,969 shares to 391,536,144 shares, with the proportion of restricted shares dropping from 0.88% to 0.50% [5]. - The repurchase will not significantly impact the company's financial status, operational results, or equity distribution, nor will it affect the management team's diligence or the continuation of the incentive plan [5].
艾德生物: 关于部分限制性股票回购注销完成的公告